Skip to content
Disclosery

ADAR1 Capital Management, LLC

Follow

13F filer, CIK 1940272, AUSTIN, TX

ADAR1 Capital Management, LLC reported $652,087,677 across 210 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 49.49% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001940272-25-000005

Period
2025-06-30
Reported value
$652M
Holdings
210
Top 10 weight
49.49%
New
50
Sold out
42

Part of the filer group ADAR1 Capital Management, LLC

How groups are built

Stakes and trades reported after 2025-06-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KROSadded+3,902,803$52.1M
PRTAnew+3,375,009$20.5M
SPYnew+22,684$14M
CTMXadded+3,034,378$6.89M
ABVXadded+861,321$6.59M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ROIVreduced-1,542,607-$17.4M
SPRINGWORKS THERAPEUTICS INCreduced-183,696-$8.63M
RAPT THERAPEUTICS INCexited-5,970,768-$7.28M
IMVTreduced-433,800-$6.94M
INTRA-CELLULAR THERAPIES INCexited-48,044-$6.34M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001940272-25-000005, largest first. % of portfolio is the value over $615,875,250, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KROSKEROS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 445,068 shares; 2024Q4: 23,246 shares; 2025Q1: 1,486,461 shares; 2025Q2: 5,389,264 shares 5,389,264$71.9M11.68%+3,902,803Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 981,295 shares; 2024Q4: 1,020,333 shares; 2025Q1: 939,669 shares; 2025Q2: 948,069 shares 948,069$52.4M8.51%+8,400Timeline
BOXXEA SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 323,382 shares; 2024Q4: 325,450 shares; 2025Q1: 337,125 shares; 2025Q2: 337,125 shares 337,125$38M6.17%0Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 532,454 shares; 2024Q4: 1,045,837 shares; 2025Q1: 940,858 shares; 2025Q2: 850,437 shares 850,437$29.7M4.83%-90,421Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 521,612 shares; 2024Q4: 1,513,393 shares; 2025Q1: 2,210,019 shares; 2025Q2: 3,071,340 shares 3,071,340$23.5M3.82%+861,321Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,025,450 shares; 2024Q4: 3,508,694 shares; 2025Q1: 3,483,404 shares; 2025Q2: 1,940,797 shares 1,940,797$21.9M3.55%-1,542,607Timeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,375,009 shares 3,375,009$20.5M3.33%newTimeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 911,182 shares; 2024Q4: 414,209 shares; 2025Q1: 390,729 shares; 2025Q2: 582,147 shares 582,147$19.2M3.12%+191,418Timeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,684 shares 22,684$14M2.28%newTimeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 143,104 shares; 2024Q4: 215,750 shares; 2025Q1: 301,134 shares; 2025Q2: 523,216 shares 523,216$13.6M2.21%+222,082Timeline
BILSPDR SERIES TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,786 shares; 2024Q4: 131,786 shares; 2025Q1: 135,585 shares; 2025Q2: 135,585 shares 135,585$12.4M2.02%0Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,448,470 shares; 2024Q4: 678,857 shares; 2025Q1: 339,635 shares; 2025Q2: 259,659 shares 259,659$11.2M1.82%-79,976Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 5,103,005 shares; 2025Q1: 5,122,105 shares; 2025Q2: 5,122,105 shares 5,122,105$9.99M1.62%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 720,848 shares; 2025Q2: 847,227 shares 847,227$8.96M1.45%+126,379Timeline
ABUSARBUTUS BIOPHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,089,321 shares; 2024Q4: 1,554,802 shares; 2025Q1: 1,879,114 shares; 2025Q2: 2,825,773 shares 2,825,773$8.73M1.42%+946,659Timeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,560 shares; 2024Q4: 515,138 shares; 2025Q1: 804,220 shares; 2025Q2: 875,983 shares 875,983$8.6M1.4%+71,763
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,131,707 shares; 2024Q4: 787,478 shares; 2025Q1: 968,866 shares; 2025Q2: 535,066 shares 535,066$8.56M1.39%-433,800Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 742,634 shares; 2024Q4: 988,468 shares; 2025Q1: 1,360,291 shares; 2025Q2: 3,600,670 shares 3,600,670$8.21M1.33%+2,240,379Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 27,903 shares; 2024Q4: 50,547 shares; 2025Q1: 127,548 shares; 2025Q2: 259,503 shares 259,503$8.12M1.32%+131,955Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 123,037 shares; 2025Q1: 971,100 shares; 2025Q2: 1,937,123 shares 1,937,123$8M1.3%+966,023Timeline
FRNMPERCEPTIVE CAP SOLUTIONS CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 750,000 shares; 2024Q4: 750,000 shares; 2025Q1: 750,000 shares; 2025Q2: 750,000 shares 750,000$7.96M1.29%0Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 220,906 shares; 2024Q4: not reported; 2025Q1: 1,471,587 shares; 2025Q2: 1,205,101 shares 1,205,101$7.72M1.25%-266,486Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 903,959 shares; 2024Q4: 145,036 shares; 2025Q1: 47,036 shares; 2025Q2: 3,081,414 shares 3,081,414$6.99M1.14%+3,034,378Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 251,400 shares; 2024Q4: 177,707 shares; 2025Q1: 1,066,309 shares; 2025Q2: 3,009,870 shares 3,009,870$6.95M1.13%+1,943,561Timeline
SAGE THERAPEUTICS INCSAGE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 51,650 shares; 2024Q4: 19,200 shares; 2025Q1: 742,495 shares; 2025Q2: 721,599 shares 721,599$6.58M1.07%-20,896
RAPTRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 783,217 shares 783,217$6.27M1.02%newTimeline
AAMAA MISSION ACQUISITION COR-AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,010,199 shares; 2024Q4: 560,199 shares; 2025Q1: 578,359 shares; 2025Q2: 578,359 shares 578,359$6.03M0.98%0Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 700 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 148,461 shares 148,461$5.87M0.95%newTimeline
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 108,171 shares; 2024Q4: 146,671 shares; 2025Q1: 523,767 shares; 2025Q2: 345,878 shares 345,878$5.8M0.94%-177,889Timeline
OACCUOAKTREE ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 500,000 shares; 2025Q1: 516,482 shares; 2025Q2: 516,482 shares 516,482$5.48M0.89%0Timeline
VERVE THERAPEUTICS INCVERVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 469,018 shares 469,018$5.27M0.86%new
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,351 shares; 2024Q4: 170,000 shares; 2025Q1: 177,136 shares; 2025Q2: 134,136 shares 134,136$4.93M0.8%-43,000Timeline
HELIX ACQUISITION CORP IIHELIX ACQUISITION CORP IIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 404,138 shares; 2024Q4: 404,138 shares; 2025Q1: 469,729 shares; 2025Q2: 442,615 shares 442,615$4.7M0.76%-27,114
SHYISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 103,337 shares; 2025Q2: 53,337 shares 53,337$4.42M0.72%-50,000Timeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,571,705 shares; 2024Q4: 1,359,208 shares; 2025Q1: 1,116,047 shares; 2025Q2: 989,297 shares 989,297$4.41M0.72%-126,750Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 729,401 shares; 2024Q4: 841,541 shares; 2025Q1: 263,425 shares; 2025Q2: 302,125 shares 302,125$4.09M0.66%+38,700Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,302 shares; 2024Q4: 154,027 shares; 2025Q1: 216,166 shares; 2025Q2: 296,766 shares 296,766$3.9M0.63%+80,600Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 130,037 shares; 2025Q1: 100,774 shares; 2025Q2: 100,974 shares 100,974$3.61M0.59%+200Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,100 shares; 2024Q4: 40,002 shares; 2025Q1: 122,921 shares; 2025Q2: 210,313 shares 210,313$3.6M0.58%+87,392Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,400 shares; 2024Q4: 31,035 shares; 2025Q1: 490,743 shares; 2025Q2: 915,130 shares 915,130$3.59M0.58%+424,387Timeline
THRDTHIRD HARMONIC BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: 622,873 shares 622,873$3.38M0.55%+522,873Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,097 shares; 2024Q4: not reported; 2025Q1: 12,800 shares; 2025Q2: 98,032 shares 98,032$3.19M0.52%+85,232Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 30,941 shares; 2025Q1: 36,890 shares; 2025Q2: 45,390 shares 45,390$2.87M0.47%+8,500Timeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 29,100 shares; 2025Q1: 20,000 shares; 2025Q2: 28,450 shares 28,450$2.69M0.44%+8,450
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 428,802 shares; 2024Q4: 368,330 shares; 2025Q1: 380,330 shares; 2025Q2: 1,723,526 shares 1,723,526$2.41M0.39%+1,343,196Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,206 shares; 2024Q4: 26,000 shares; 2025Q1: 79,000 shares; 2025Q2: 170,598 shares 170,598$2.38M0.39%+91,598Timeline
ASPCA SPAC III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 215,000 shares; 2025Q2: 215,000 shares 215,000$2.2M0.36%0Timeline
CRMDCORMEDIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 175,000 shares 175,000$2.16M0.35%newTimeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 112,359 shares 112,359$2.03M0.33%newTimeline
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 31,052 shares; 2024Q4: 149,385 shares; 2025Q1: 149,385 shares; 2025Q2: 149,385 shares 149,385$2.03M0.33%0Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,052,968 shares; 2025Q1: 1,678,063 shares; 2025Q2: 531,515 shares 531,515$2.01M0.33%-1,146,548Timeline
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,100 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,000 shares 15,000$1.92M0.31%new
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,100 shares; 2024Q4: 9,300 shares; 2025Q1: 59,413 shares; 2025Q2: 67,813 shares 67,813$1.8M0.29%+8,400Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,007 shares; 2024Q4: 15,307 shares; 2025Q1: 71,143 shares; 2025Q2: 33,143 shares 33,143$1.77M0.29%-38,000Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 871 shares; 2024Q4: 1,361 shares; 2025Q1: 1,361 shares; 2025Q2: 3,361 shares 3,361$1.76M0.29%+2,000Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 569,008 shares; 2024Q4: 170,129 shares; 2025Q1: 350,352 shares; 2025Q2: 207,818 shares 207,818$1.71M0.28%-142,534Timeline
DVAXDYNAVAX TECHNOLOGIES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 170,000 shares; 2025Q2: 170,000 shares 170,000$1.69M0.27%0Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,457 shares; 2024Q4: 17,424 shares; 2025Q1: 5,424 shares; 2025Q2: 34,314 shares 34,314$1.62M0.26%+28,890Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,187 shares; 2024Q4: not reported; 2025Q1: 132,780 shares; 2025Q2: 142,780 shares 142,780$1.6M0.26%+10,000Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 436,668 shares; 2024Q4: 166,406 shares; 2025Q1: 41,412 shares; 2025Q2: 56,540 shares 56,540$1.56M0.25%+15,128Timeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 88,425 shares; 2024Q4: 53,125 shares; 2025Q1: 53,125 shares; 2025Q2: 53,125 shares 53,125$1.53M0.25%0Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 127,159 shares; 2024Q4: 58,708 shares; 2025Q1: 62,603 shares; 2025Q2: 73,505 shares 73,505$1.46M0.24%+10,902Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 36,830 shares; 2025Q1: 18,830 shares; 2025Q2: 17,330 shares 17,330$1.45M0.24%-1,500Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 13,000 shares; 2024Q4: 31,509 shares; 2025Q1: 153,767 shares; 2025Q2: 62,088 shares 62,088$1.43M0.23%-91,679Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,000 shares; 2024Q4: 19,505 shares; 2025Q1: 157,079 shares; 2025Q2: 39,677 shares 39,677$1.41M0.23%-117,402Timeline
ASTRIA THERAPEUTICS INCASTRIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,284 shares; 2024Q4: 90,984 shares; 2025Q1: 641,690 shares; 2025Q2: 249,646 shares 249,646$1.34M0.22%-392,044
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 74,431 shares; 2024Q4: 10,188 shares; 2025Q1: not reported; 2025Q2: 45,000 shares 45,000$1.29M0.21%newTimeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 319,185 shares; 2024Q4: 64,067 shares; 2025Q1: 250,000 shares; 2025Q2: 250,000 shares 250,000$1.26M0.2%0Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,300 shares; 2024Q4: not reported; 2025Q1: 27,900 shares; 2025Q2: 35,900 shares 35,900$1.19M0.19%+8,000Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,000 shares; 2024Q4: not reported; 2025Q1: 14,600 shares; 2025Q2: 57,466 shares 57,466$1.17M0.19%+42,866Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 100 shares; 2024Q4: not reported; 2025Q1: 207,778 shares; 2025Q2: 24,082 shares 24,082$1.13M0.18%-183,696
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,000 shares; 2024Q4: not reported; 2025Q1: 8,000 shares; 2025Q2: 25,000 shares 25,000$1.07M0.17%+17,000Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 94,294 shares; 2025Q1: 146,183 shares; 2025Q2: 916,183 shares 916,183$1.06M0.17%+770,000Timeline
CDTXCIDARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 24,938 shares; 2025Q1: 20,938 shares; 2025Q2: 21,522 shares 21,522$1.05M0.17%+584Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,770,649 shares; 2024Q4: 2,077,251 shares; 2025Q1: 2,801,184 shares; 2025Q2: 997,547 shares 997,547$1.05M0.17%-1,803,637Timeline
BSAAUBEST SPAC I ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 100,000 shares 100,000$1M0.16%newTimeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 110 shares; 2024Q4: not reported; 2025Q1: 600 shares; 2025Q2: 1,759 shares 1,759$970K0.16%+1,159Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 153,286 shares; 2024Q4: 81,460 shares; 2025Q1: 66,960 shares; 2025Q2: 18,313 shares 18,313$963K0.16%-48,647
ALDXALDEYRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 302,212 shares; 2024Q4: 647,960 shares; 2025Q1: 211,579 shares; 2025Q2: 249,920 shares 249,920$957K0.16%+38,341Timeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,950 shares; 2024Q4: 35,050 shares; 2025Q1: 41,050 shares; 2025Q2: 39,400 shares 39,400$955K0.16%-1,650Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 20,400 shares; 2024Q4: not reported; 2025Q1: 313,354 shares; 2025Q2: 128,767 shares 128,767$948K0.15%-184,587Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,962 shares; 2024Q4: 3,962 shares; 2025Q1: 13,962 shares; 2025Q2: 13,962 shares 13,962$919K0.15%0Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,442 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 11,842 shares 11,842$904K0.15%newTimeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 62,423 shares; 2024Q4: 34,693 shares; 2025Q1: 68,741 shares; 2025Q2: 155,557 shares 155,557$896K0.15%+86,816Timeline
SGRYSURGERY PARTNERS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 40,000 shares; 2025Q2: 40,000 shares 40,000$889K0.14%0Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,705 shares; 2024Q4: 12,900 shares; 2025Q1: 56,300 shares; 2025Q2: 55,200 shares 55,200$872K0.14%-1,100Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 49,451 shares; 2024Q4: 57,978 shares; 2025Q1: 68,715 shares; 2025Q2: 68,815 shares 68,815$859K0.14%+100Timeline
KVACFKEEN VISION ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 75,000 shares 75,000$853K0.14%newTimeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 163,078 shares; 2024Q4: 121,461 shares; 2025Q1: 420,765 shares; 2025Q2: 420,765 shares 420,765$842K0.14%0Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 57,183 shares; 2024Q4: 41,274 shares; 2025Q1: 104,853 shares; 2025Q2: 18,070 shares 18,070$785K0.13%-86,783Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 21,700 shares; 2025Q1: 23,100 shares; 2025Q2: 114,814 shares 114,814$746K0.12%+91,714Timeline
KALAKALA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 306,067 shares; 2024Q4: 220,373 shares; 2025Q1: 298,955 shares; 2025Q2: 149,830 shares 149,830$713K0.12%-149,125Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 237,605 shares 237,605$687K0.11%newTimeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,300 shares; 2024Q4: 211,400 shares; 2025Q1: 241,800 shares; 2025Q2: 275,800 shares 275,800$676K0.11%+34,000Timeline
KZRKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,338,273 shares; 2024Q4: 147,404 shares; 2025Q1: 147,404 shares; 2025Q2: 147,404 shares 147,404$675K0.11%0Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 342,262 shares; 2024Q4: 234,607 shares; 2025Q1: 398,152 shares; 2025Q2: 85,826 shares 85,826$675K0.11%-312,326Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,967 shares; 2024Q4: 82,234 shares; 2025Q1: 168,765 shares; 2025Q2: 166,799 shares 166,799$662K0.11%-1,966Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 29,625 shares; 2024Q4: 3,045 shares; 2025Q1: 4,500 shares; 2025Q2: 5,100 shares 5,100$641K0.1%+600Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 557,159 shares; 2024Q4: 337,676 shares; 2025Q1: 266,176 shares; 2025Q2: 441,176 shares 441,176$622K0.1%+175,000Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 200 shares; 2024Q4: 55,400 shares; 2025Q1: 42,800 shares; 2025Q2: 63,424 shares 63,424$608K0.1%+20,624Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 34,124 shares 34,124$601K0.1%newTimeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 57,166 shares; 2024Q4: 169,505 shares; 2025Q1: 170,448 shares; 2025Q2: 145,109 shares 145,109$583K0.09%-25,339Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,856 shares; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 13,366 shares 13,366$583K0.09%+3,366Timeline
OABIOMNIAB INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,337,302 shares; 2024Q4: 278,108 shares; 2025Q1: 126,108 shares; 2025Q2: 326,108 shares 326,108$567K0.09%+200,000Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,140 shares; 2024Q4: 2,440 shares; 2025Q1: not reported; 2025Q2: 7,040 shares 7,040$557K0.09%newTimeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 28,221 shares; 2025Q1: not reported; 2025Q2: 204,497 shares 204,497$530K0.09%newTimeline
GRCEGRACE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 959,571 shares; 2024Q4: 773,635 shares; 2025Q1: 343,512 shares; 2025Q2: 176,627 shares 176,627$525K0.09%-166,885Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,178 shares; 2024Q4: not reported; 2025Q1: 20,000 shares; 2025Q2: 40,000 shares 40,000$524K0.09%+20,000Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,000 shares; 2025Q2: 104,730 shares 104,730$523K0.08%+94,730Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,560 shares; 2024Q4: not reported; 2025Q1: 15,033 shares; 2025Q2: 34,051 shares 34,051$510K0.08%+19,018Timeline
USFRWISDOMTREE TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares 10,000$503K0.08%0Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 101,826 shares; 2024Q4: 44,826 shares; 2025Q1: 13,873 shares; 2025Q2: 35,716 shares 35,716$500K0.08%+21,843Timeline
SNYSANOFI SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 99,600 shares; 2025Q1: not reported; 2025Q2: 10,000 shares 10,000$483K0.08%newTimeline
KPRXKIORA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 196,551 shares; 2024Q4: 200,221 shares; 2025Q1: 194,665 shares; 2025Q2: 167,111 shares 167,111$481K0.08%-27,554Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,637 shares; 2024Q4: not reported; 2025Q1: 22,641 shares; 2025Q2: 32,341 shares 32,341$456K0.07%+9,700Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 553 shares; 2024Q4: not reported; 2025Q1: 27,925 shares; 2025Q2: 29,625 shares 29,625$443K0.07%+1,700Timeline
NABORS ENERGY TRANSITION CORNABORS ENERGY TRANSITION CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 59,900 shares; 2024Q4: 39,900 shares; 2025Q1: 39,900 shares; 2025Q2: 39,900 shares 39,900$443K0.07%0
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,250 shares; 2025Q2: 2,500 shares 2,500$422K0.07%-1,750Timeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 743,459 shares; 2024Q4: 801,277 shares; 2025Q1: 801,277 shares; 2025Q2: 143,917 shares 143,917$417K0.07%-657,360Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,796 shares 15,796$408K0.07%newTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,150 shares; 2024Q4: 1,350 shares; 2025Q1: 600 shares; 2025Q2: 500 shares 500$390K0.06%-100Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 122,690 shares; 2025Q1: 122,690 shares; 2025Q2: 122,690 shares 122,690$372K0.06%0Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 55,802 shares; 2024Q4: 196,248 shares; 2025Q1: 490,532 shares; 2025Q2: 53,349 shares 53,349$367K0.06%-437,183Timeline
PYPDPOLYPID LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,902 shares; 2024Q4: 80,080 shares; 2025Q1: 80,080 shares; 2025Q2: 103,950 shares 103,950$367K0.06%+23,870Timeline
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 97,955 shares; 2024Q4: 124,530 shares; 2025Q1: 281,600 shares; 2025Q2: 168,600 shares 168,600$361K0.06%-113,000Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 11,000 shares; 2025Q1: 21,200 shares; 2025Q2: 31,200 shares 31,200$355K0.06%+10,000Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50 shares; 2024Q4: not reported; 2025Q1: 1,490 shares; 2025Q2: 1,054 shares 1,054$319K0.05%-436Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 35,319 shares; 2025Q1: 35,619 shares; 2025Q2: 15,000 shares 15,000$311K0.05%-20,619Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 30,085 shares; 2025Q2: 27,285 shares 27,285$310K0.05%-2,800Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 17,252 shares; 2024Q4: 15,000 shares; 2025Q1: 17,000 shares; 2025Q2: 17,000 shares 17,000$294K0.05%0Timeline
ANSCAGRICULTURE & NAT SOL ACQ COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 80,362 shares; 2024Q4: 80,362 shares; 2025Q1: 47,062 shares; 2025Q2: 27,062 shares 27,062$294K0.05%-20,000Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,750 shares 2,750$292K0.05%newTimeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 416,958 shares; 2024Q4: 295,613 shares; 2025Q1: 227,228 shares; 2025Q2: 227,228 shares 227,228$279K0.05%0Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,200 shares; 2024Q4: not reported; 2025Q1: 4,900 shares; 2025Q2: 4,900 shares 4,900$269K0.04%0Timeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 376,737 shares; 2024Q4: 131,599 shares; 2025Q1: 101,096 shares; 2025Q2: 26,937 shares 26,937$269K0.04%-74,159
UCFICN HEALTHY FOOD TECH GROUP CQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,000 shares; 2024Q4: 25,000 shares; 2025Q1: 25,000 shares; 2025Q2: 25,000 shares 25,000$258K0.04%0Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,000 shares 12,000$255K0.04%newTimeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,634 shares; 2024Q4: 126,792 shares; 2025Q1: 75,545 shares; 2025Q2: 79,945 shares 79,945$249K0.04%+4,400Timeline
TXMDTHERAPEUTICSMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 270,160 shares; 2024Q4: 270,160 shares; 2025Q1: 270,160 shares; 2025Q2: 209,210 shares 209,210$243K0.04%-60,950Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 161,402 shares; 2024Q4: 71,402 shares; 2025Q1: 1,402 shares; 2025Q2: 1,402 shares 1,402$242K0.04%0Timeline
QNCXQUINCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 142,958 shares; 2024Q4: 142,958 shares; 2025Q1: 142,958 shares; 2025Q2: 142,958 shares 142,958$236K0.04%0Timeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 373,835 shares; 2024Q4: 351,094 shares; 2025Q1: 351,094 shares; 2025Q2: 351,094 shares 351,094$230K0.04%0Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 400 shares; 2024Q4: not reported; 2025Q1: 30,099 shares; 2025Q2: 23,063 shares 23,063$220K0.04%-7,036Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,440 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,875 shares 22,875$213K0.03%newTimeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,000 shares; 2024Q4: not reported; 2025Q1: 25,000 shares; 2025Q2: 34,300 shares 34,300$198K0.03%+9,300Timeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 53,111 shares; 2024Q4: 53,023 shares; 2025Q1: 28,023 shares; 2025Q2: 28,023 shares 28,023$182K0.03%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,000 shares; 2024Q4: 15,000 shares; 2025Q1: 15,000 shares; 2025Q2: 35,000 shares 35,000$177K0.03%+20,000Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 30,000 shares 30,000$164K0.03%newTimeline
COLOMBIERACQUISITIONCORPICOLOMBIERACQUISITIONCORPIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 18,513 shares; 2025Q2: 10,000 shares 10,000$155K0.03%-8,513
AVXLANAVEX LIFE SCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 16,221 shares; 2025Q1: 16,221 shares; 2025Q2: 16,221 shares 16,221$150K0.02%0Timeline
INOZYME PHARMA INCINOZYME PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 76,299 shares; 2025Q1: 87,799 shares; 2025Q2: 37,161 shares 37,161$149K0.02%-50,638
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 163,443 shares; 2024Q4: 48,125 shares; 2025Q1: 119,320 shares; 2025Q2: 119,320 shares 119,320$148K0.02%0Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 42,408 shares 42,408$143K0.02%newTimeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares 10,000$137K0.02%newTimeline
BIOMX INCBIOMX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 432,700 shares; 2024Q4: not reported; 2025Q1: 299,598 shares; 2025Q2: 299,598 shares 299,598$135K0.02%0
CLOVCLOVER HEALTH INVESTMENTS COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 23,300 shares; 2025Q1: 28,300 shares; 2025Q2: 48,300 shares 48,300$135K0.02%+20,000Timeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares 10,000$135K0.02%newTimeline
PROCAP ACQUISITION CORPPROCAP ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,680 shares 10,680$114K0.02%new
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,788 shares 37,788$113K0.02%newTimeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,143 shares; 2024Q4: 35,843 shares; 2025Q1: 35,743 shares; 2025Q2: 10,000 shares 10,000$113K0.02%-25,743Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,290 shares; 2024Q4: 18,000 shares; 2025Q1: 18,643 shares; 2025Q2: 18,643 shares 18,643$108K0.02%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 101,008 shares; 2024Q4: 101,008 shares; 2025Q1: 101,008 shares; 2025Q2: 101,008 shares 101,008$107K0.02%0Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 24,702 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 28,415 shares 28,415$106K0.02%newTimeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,970 shares; 2024Q4: not reported; 2025Q1: 23,799 shares; 2025Q2: 27,787 shares 27,787$101K0.02%+3,988Timeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 91 shares; 2024Q4: 13,173 shares; 2025Q1: 43,173 shares; 2025Q2: 43,173 shares 43,173$97.6K0.02%0Timeline
OGNORGANON & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,100 shares; 2024Q4: 40,200 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares 10,000$96.8K0.02%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,400 shares 10,400$96.6K0.02%newTimeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 246,128 shares; 2024Q4: 134,798 shares; 2025Q1: not reported; 2025Q2: 82,189 shares 82,189$95.3K0.02%newTimeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 350,206 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares 10,000$93.7K0.02%newTimeline
ESSA PHARMA INCESSA PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares 50,000$85K0.01%new
AUPHAURINIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares 10,000$84.7K0.01%newTimeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 102,156 shares; 2025Q2: 102,948 shares 102,948$81.5K0.01%+792Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 130,000 shares 130,000$78K0.01%newTimeline
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 170,506 shares 170,506$67.5K0.01%newTimeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 25,000 shares 25,000$65K0.01%newTimeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,823 shares 10,823$62.4K0.01%newTimeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares 50,000$58K0.01%newTimeline
NEXTCURE INCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 120,013 shares; 2024Q4: 120,012 shares; 2025Q1: 120,012 shares; 2025Q2: 118,012 shares 118,012$54.3K0.01%-2,000
CASIFCASI PHARMACEUTICALS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 64,835 shares; 2024Q4: 46,320 shares; 2025Q1: 47,420 shares; 2025Q2: 44,120 shares 44,120$52.1K0.01%-3,300Timeline
AA MISSION ACQUISITI…AA MISSION ACQUISITION …Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 505,099 shares; 2024Q4: 505,099 shares; 2025Q1: 505,099 shares; 2025Q2: 505,099 shares 505,099$49.7K0.01%0
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 16,000 shares; 2025Q1: 16,600 shares; 2025Q2: 16,900 shares 16,900$45.8K0.01%+300Timeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 476,212 shares; 2024Q4: 415,606 shares; 2025Q1: not reported; 2025Q2: 54,819 shares 54,819$41.8K0.01%newTimeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 37,743 shares; 2024Q4: 130,532 shares; 2025Q1: 115,867 shares; 2025Q2: 115,867 shares 115,867$38.2K0.01%0Timeline
ASPCRA SPAC III ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 215,000 shares; 2025Q2: 215,000 shares 215,000$36.5K0.01%0Timeline
MURAL ONCOLOGY PUB LTD COMURAL ONCOLOGY PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 11,855 shares 11,855$29.3K<0.01%new
RNXTRENOVORX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 315,192 shares; 2024Q4: 197,250 shares; 2025Q1: 479,883 shares; 2025Q2: 19,889 shares 19,889$26.2K<0.01%-459,994Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares 10,000$23.9K<0.01%0Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 20,352 shares; 2025Q2: 20,352 shares 20,352$22.6K<0.01%0Timeline
NERVMINERVA NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,406 shares 12,406$21.3K<0.01%newTimeline
JVSPAC ACQUISITION CORPJVSPAC ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,000 shares; 2024Q4: 30,000 shares; 2025Q1: 30,000 shares; 2025Q2: 24,000 shares 24,000$20.9K<0.01%-6,000
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 20,394 shares; 2025Q1: 20,394 shares; 2025Q2: 10,000 shares 10,000$20.4K<0.01%-10,394Timeline
ILLUMINA INC COMILLUMINA INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,159,826 shares; 2024Q4: 19,146 shares; 2025Q1: 19,146 shares; 2025Q2: 19,146 shares 19,146$13K<0.01%0
CYPHCYPHERPUNK TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 106,000 shares; 2025Q1: 111,000 shares; 2025Q2: 39,925 shares 39,925$11.9K<0.01%-71,075Timeline
CONNECT BIOPHARMA HLDGS LTDCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,300 shares; 2025Q2: 10,300 shares 10,300$10.1K<0.01%0
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,366 shares 10,366$7.58K<0.01%newTimeline
RTS/IRON HORSE ACQUISITIONS…RTS/IRON HORSE ACQUISITIONS CORP …Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,000 shares; 2024Q4: 25,000 shares; 2025Q1: 25,000 shares; 2025Q2: 12,320 shares 12,320$6.14K<0.01%-12,680
KVACWKEEN VISION ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 75,000 shares 75,000$4.05K<0.01%newTimeline
00Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 13,144 shares; 2024Q4: 13,144 shares; 2025Q1: 13,144 shares; 2025Q2: 13,144 shares 13,144$1.5K<0.01%0
EMCWFEMBRACE CHANGE ACQUISITION CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,000 shares; 2024Q4: 18,000 shares; 2025Q1: 18,000 shares; 2025Q2: 18,000 shares 18,000$360<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPYSTATE STR SPDR S&P 500 ETF T SHSput40,500$25Mnew
JANXJANUX THERAPEUTICS INC COMcall264,900$6.12M0
SMMTSUMMIT THERAPEUTICS INC COMcall100,000$2.13M0
SRPTSAREPTA THERAPEUTICS INC COMcall55,000$940Knew
NKTRNEKTAR THERAPEUTICS COMMON STOCKput35,000$904Knew
BHVNBIOHAVEN LTD COMcall25,000$353Knew
INMBINMUNE BIO INC COMput130,200$301Knew
ATYRATYR PHARMA INC COM NEWput50,000$254Knew
DYNDYNE THERAPEUTICS INC Stockcall20,000$190Knew

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC Convertibleprincipal4,500,000$4.19M0
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC NOTE 2.500% 3/1principal2,000,000$2.49M0

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC5,970,768$7.28Mshares
INTRA-CELLULAR THERAPIES INCINTRA-CELLULAR THERAPIES INC48,044$6.34Mshares
NVSNOVARTIS AG50,000$5.57Mput
COHERUS ONCOLOGY INCCOHERUS ONCOLOGY INC5,625,000$5.48Mprincipal
AEROVATE THERAPEUTICS INCAEROVATE THERAPEUTICS INC1,461,234$3.67Mshares
SLNOSOLENO THERAPEUTICS INC50,000$3.57Mput
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC2,666,627$2.74Mprincipal
PTCTPTC THERAPEUTICS INC50,023$2.55Mshares
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COM341,515$1.39Mshares
Checkpoint Therapeutics IncCheckpoint Therapeutics Inc305,800$1.24Mshares
ARES ACQUISITION CORP IIARES ACQUISITION CORP II90,466$1.01Mshares
KEEN VISION ACQUISITION CORPKEEN VISION ACQUISITION CORP75,000$842Kshares
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC15,000$662Kcall
ZYMEZYMEWORKS INC50,000$596Kshares
INSMINSMED INC6,074$463Kshares
BNTXBIONTECH SE5,000$455Kshares
TILINSTIL BIO INC24,328$422Kshares
ISRGINTUITIVE SURGICAL INC700$347Kshares
DNTHDIANTHUS THERAPEUTICS INC18,285$332Kshares
JVSPAC ACQUISITION CORPJVSPAC ACQUISITION CORP30,000$322Kshares
NORDSTROM INCNORDSTROM INC12,000$293Kshares
EXASEXACT SCIENCES CORP5,000$216Kshares
IMNMIMMUNOME INC20,000$135Kshares
SLDBSOLID BIOSCIENCES INC34,479$128Kshares
SPRUCE BIOSCIENCES INCSPRUCE BIOSCIENCES INC403,716$117Kshares
VYNEVYNE THERAPEUTICS INC70,419$111Kshares
AQNALGONQUIN POWER & UTILITIES20,000$103Kshares
BOLT BIOTHERAPEUTICS INCBOLT BIOTHERAPEUTICS INC244,966$98Kshares
UPBUPSTREAM BIO INC15,000$91.8Kshares
BCRXBIOCRYST PHARMACEUTICALS INC10,000$75Kshares
LYRA THERAPEUTICS INCLYRA THERAPEUTICS INC533,200$67.3Kshares
PHATPHATHOM PHARMACEUTICALS INC10,100$63.3Kcall
ADGMADAGIO MED HLDGS INC76,757$61.8Kshares
TNGXTANGO THERAPEUTICS INC41,346$56.6Kshares
IOVAIOVANCE BIOTHERAPEUTICS INC15,700$52.3Kshares
NEKTAR THERAPEUTICSNEKTAR THERAPEUTICS67,754$46.1Kshares
XLOXilio Therapeutics Inc.40,000$29Kshares
NMRANEUMORA THERAPEUTICS INC.26,108$26.1Kshares
MREOMEREO BIOPHARMA GROUP PLC10,000$22.5Kshares
CELLECTAR BIOSCIENCES INCCELLECTAR BIOSCIENCES INC40,228$12.7Kshares
RALLYBIO CORPRALLYBIO CORP13,400$8.77Kshares
CN HEALTHY FOOD TECH GROUP CCN HEALTHY FOOD TECH GROUP C25,000$800shares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001940272-25-000005 base2025-08-14acceptance time not in the bulk data set